Characteristics of Human Leukocyte Antigen Class II Genes in Japanese Patients with Type 1 Diabetes and Autoimmune Thyroid Disease.


Journal

The Tohoku journal of experimental medicine
ISSN: 1349-3329
Titre abrégé: Tohoku J Exp Med
Pays: Japan
ID NLM: 0417355

Informations de publication

Date de publication:
09 Jul 2024
Historique:
medline: 11 7 2024
pubmed: 2 5 2024
entrez: 1 5 2024
Statut: ppublish

Résumé

Genetic factors, particularly human leukocyte antigen (HLA) class II genes, are known to significantly influence the onset of type 1 diabetes (T1D). Additionally, patients with T1D often develop autoimmune thyroid diseases (AITD). Despite this association, comprehensive research on individuals with both AITD and T1D in Japan, especially regarding the influence of specific HLA alleles, remains insufficient. In this retrospective study, we analyzed 44 inpatients diagnosed with T1D. These patients were predominantly female, with an average onset age of 35 years, poor blood sugar control, and approximately 43.2% had concurrent AITD. We observed significant associations of HLA-DRB1*04:05, HLA-DRB1*09:01 and HLA-DRB1*15:02 alleles with T1D regardless of AITD presence, which had been previously established for T1D in Japanese. In this context, comparing Japanese patients with AITD alone, we noted AITD comorbidity with T1D results in alterations in the frequencies of HLA-DRB1*09:01, HLA-DRB1*04:03, and HLA-DRB1*15:02. Furthermore, HLA-DRB1*04:05, HLA-DRB1*09:01, HLA-DRB1*13:02, and HLA-DRB1*15:01 alleles may be alleles whose susceptibility varies for both conditions. These findings underscore the importance of understanding the relationship between T1D, AITD, and HLA genetics, which may inform personalized treatment strategies and facilitate the development of targeted therapies. Future research endeavors should aim to elucidate underlying mechanisms and validate these findings in larger cohorts.

Identifiants

pubmed: 38692862
doi: 10.1620/tjem.2024.J027
doi:

Substances chimiques

HLA-DRB1 Chains 0
Histocompatibility Antigens Class II 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-139

Auteurs

Risa Kajita (R)

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine.

Haruna Takahashi (H)

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine.

Satoshi Yoshino (S)

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine.

Shunichi Matsumoto (S)

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine.

Kazuhiko Horiguchi (K)

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine.

Shuichi Okada (S)

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine.

Masanobu Yamada (M)

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine.

Eijiro Yamada (E)

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH